According to a story from HSC News, Dr. Peter Kuhn from the University of South Carolina (USC) is developing a navigational tool that aims to personalize treatment based on a…
What do Dave Winfield, Steve Garvey, and Don Baylor Jr. all have in common? Besides all being big names in major league baseball, each of the famous athletes is contributing…
As vice chair of the National Comprehensive Cancer Network ‘s (NCCN) committee on multiple myeloma, Dr. Natalie Callander helps to set guidelines for effective evaluation and treatment. The NCCN commonly…
According to a story from the Washington Post, a new technique for delivering genes into immune system T cells could make immunotherapy a much more accessible option for treating rare…
Gene-editing therapies have made almost constant news headlines in relations to cancer treatment. The process of reprogramming the body’s immune cells to fight cancer seems more and more promising. The…
According to a story from Hematology Times, a medicine called melflufen, of the alkylating peptide class, appears to be effective in treatment resistant multiple myeloma. In a Phase 2 trial,…
According to a story from Deseret News, after she was diagnosed with multiple myeloma, Jenny Ahlstrom almost immediately had to make crucial decisions regarding her treatment: decisions that could mean…
According to uk.reuters.com, the pharmaceutical company Sanofi is playing catch up to put itself ahead of the competition in developing the new cancer treatments. The French company didn't join in…
Lisa Ray starred in the 2005 film Water. She also appeared in TV shows such as Endgame, Psych, and Top Chef Canada. Now, as an advocate for people with multiple…
According to Globe Newswire, the United States Food and Drug Administration (US FDA) designated a new orphan drug for the treatment of multiple myeloma on May 9th, 2018. The drug…
According to a story from Reuters, the Danish biotech company Genmab saw its share value drop by a quarter after Johnson & Johnson, which had partnered with the company to…
The U.S. Food and Drug Administration (FDA) has just approved a drug called Darzalex (daratumumab) in combination with the drug Velcade (bortezomib), melphalan, and prednisone (known collectively as VMP) for…
Barry Du Bois, presenter of the The Living Room, announced six months that his struggle with cancer continued. Despite six years living with cancer in remission, multiple myeloma returned to…
A new study reported on by Hematology Times has found that being taught art can significantly decrease pain and anxiety, and promote a positive mood in patients with hematologic malignancies.…
The charity organisation Stand Up To Cancer (SU2C) has just announced that $10 million is going to be given to a team of researchers to fund their work to improve…
According to a story from philly.com, a pair of twins, Marilyn and Sharon Alexander, have dedicated much of their lives to cancer advocacy after a life and death battle nearly…
According to a story from watoday.com.au, Reginald Whiu, aged 73, had been complaining about back pain and was diagnosed with degeneration of the spine by his doctor. This was at…
According to a story from mysunshinecoast.com.au, an international research team has uncovered a potential biomarker that could help develop treatments for multiple myeloma, a rare form of cancer. Currently, multiple…
March is not just multiple myeloma awareness month... ...it is multiple myeloma ACTION month! Multiple myeloma is a form of cancer that develops in a type of white blood cell…
Dr. Woodrin Wright studies telomeres – the part of our DNA that determines aging. It's also involved in some cancers. It seems like a cruel irony then that Dr. Wright…
According to a story from the Canberra Times, Dan Gaffney, resident of the Blue Mountains in Australia, was denied access to a treatment that was helping to extend his life…
Multiple myeloma is a cancer of the blood that develops in the plasma cells found in soft tissue at the center of the bone, called bone marrow. Bone disease is…
Information in a Specialty Pharmacy Times report indicates that immunotherapy combined with chemotherapy may be an effective option for patients with drug-resistant multiple myeloma who have relapsed. Multiple myeloma is…
The Myra and Robert Kraft Family Foundation was established in 2016 creating an initiative to to bring together an alliance between the Harvard Business School with the Broad Institute of…
The Australian government has announced that almost that new treatments worth $300 million are being added to the Pharmaceutical Benefits Scheme. This program provides subsidized medical treatments to citizens of…
© Copyright Patient Worthy